KYNB
Kyntra Bio, Inc.Company with tickers: KYNB
CIK
921299
CUSIP
31572Q881
Shares Outstanding
4,048,112
13F Activity (30d)
35 filings
32 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $3,738,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Cost of Revenue | $4,106,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $7,566,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-13,818,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| Net Income | $-15,198,000 | USD | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-3.76 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-3.76 | USD/shares | 2026-03-31 | 10-Q | 2026-05-12 |